For research use only. Not for therapeutic Use.
PROTAC MDM2 Degrader-1(Cat No.:I018609) is a compound designed using PROTAC (Proteolysis Targeting Chimera) technology. It consists of three key components: a potent inhibitor of MDM2, a linker, and a ligand for the E3 ubiquitin ligase that targets MDM2 for degradation. By binding to MDM2, PROTAC MDM2 Degrader-1 promotes the formation of a complex that leads to the ubiquitination and subsequent degradation of MDM2. This targeted degradation of MDM2 can potentially restore normal p53 function and inhibit cancer cell growth.
Catalog Number | I018609 |
CAS Number | 2249944-98-5 |
Molecular Formula | C₇₄H₈₄Cl₄N₁₀O₁₃ |
Purity | ≥95% |
Storage | Store at -20°C |
IUPAC Name | 2-[4-[(4R,5S)-4,5-bis(4-chlorophenyl)-2-(4-methoxy-2-propan-2-yloxyphenyl)-4,5-dihydroimidazole-1-carbonyl]-2-oxopiperazin-1-yl]-N-[3-[2-[2-[3-[[2-[4-[(4R,5S)-4,5-bis(4-chlorophenyl)-2-(4-methoxy-2-propan-2-yloxyphenyl)-4,5-dihydroimidazole-1-carbonyl]-2-oxopiperazin-1-yl]acetyl]amino]propoxy]ethoxy]ethoxy]propyl]acetamide |
InChI | InChI=1S/C74H84Cl4N10O13/c1-47(2)100-61-41-57(95-5)25-27-59(61)71-81-67(49-9-17-53(75)18-10-49)69(51-13-21-55(77)22-14-51)87(71)73(93)85-33-31-83(65(91)45-85)43-63(89)79-29-7-35-97-37-39-99-40-38-98-36-8-30-80-64(90)44-84-32-34-86(46-66(84)92)74(94)88-70(52-15-23-56(78)24-16-52)68(50-11-19-54(76)20-12-50)82-72(88)60-28-26-58(96-6)42-62(60)101-48(3)4/h9-28,41-42,47-48,67-70H,7-8,29-40,43-46H2,1-6H3,(H,79,89)(H,80,90)/t67-,68-,69+,70+/m1/s1 |
InChIKey | AQFZQNOXRSZHMG-PQMVWXROSA-N |
SMILES | CC(C)OC1=C(C=CC(=C1)OC)C2=NC(C(N2C(=O)N3CCN(C(=O)C3)CC(=O)NCCCOCCOCCOCCCNC(=O)CN4CCN(CC4=O)C(=O)N5C(C(N=C5C6=C(C=C(C=C6)OC)OC(C)C)C7=CC=C(C=C7)Cl)C8=CC=C(C=C8)Cl)C9=CC=C(C=C9)Cl)C1=CC=C(C=C1)Cl |
Reference | [1]. Method of inducing of self-degradation of MDM2 using E3 ubiquitin ligase dimer amide small molecule PROTACs. CN108610333A. |